The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSMA PET guided salvage radiotherapy among patients with prostate cancer in the post-prostatectomy setting: A single center post-hoc analysis.
 
Clayton P Smith
No Relationships to Disclose
 
Wesley Robert Armstrong
No Relationships to Disclose
 
Kevyn J Clark
No Relationships to Disclose
 
Jonathan Moore
No Relationships to Disclose
 
Makayla Roberts
No Relationships to Disclose
 
Andrea Farolfi
No Relationships to Disclose
 
Robert Evan Reiter
No Relationships to Disclose
 
Matthew Rettig
Leadership - Aravalent; Survalent
Stock and Other Ownership Interests - Oncovalent Therapeutics; Survalent
Consulting or Advisory Role - Ambrx; Amgen; Clovis Oncology; Inmune Bio; Roivant
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
John Shen
Consulting or Advisory Role - AstraZeneca; Bayer; Kite/Gilead; Sanofi
Research Funding - Ambrx (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Exelixis (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Kite/Gilead; Sanofi
 
Luca Valle
No Relationships to Disclose
 
Nicholas George Nickols
Consulting or Advisory Role - Oncolinea Pharmaceuticals
Research Funding - Bayer; Janssen Scientific Affairs; Progenics; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I am listed as inventor on patents related to PyIm polyamides that have been licensed by Gene Sciences
 
Michael L. Steinberg
No Relationships to Disclose
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Advanced Accelerator Applications; Aktis Oncology; Amgen; Jubilant Radiopharma; POINT Biopharma; RayzeBio
 
Amar Upadhyaya Kishan
Stock and Other Ownership Interests - ViewRay
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Boston Scientific; Janssen
Research Funding - Janssen Oncology (Inst); Point Biopharma (Inst); ViewRay; ViewRay
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Curium Pharma; EXINI Diagnostics; Novartis; Progenics; Radiomedix
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Lantheus Medical Imaging; Novartis; POINT Biopharma; Progenics; Radiomedix; Sanofi; SOFIE; Telix Pharmaceuticals
Speakers' Bureau - Lantheus Medical Imaging
Research Funding - Progenics